DNA PROBE DIAGNOSIS OF SEXUALLY TRANSMITTED INFECTIONS

Information

  • Research Project
  • 3505926
  • ApplicationId
    3505926
  • Core Project Number
    R44AI020837
  • Full Project Number
    2R44AI020837-02A1
  • Serial Number
    20837
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/1/1984 - 39 years ago
  • Project End Date
    6/30/1988 - 36 years ago
  • Program Officer Name
  • Budget Start Date
    7/1/1986 - 38 years ago
  • Budget End Date
    6/30/1987 - 37 years ago
  • Fiscal Year
    1986
  • Support Year
    2
  • Suffix
    A1
  • Award Notice Date
    -
Organizations

DNA PROBE DIAGNOSIS OF SEXUALLY TRANSMITTED INFECTIONS

Gonococcal and Chlamydial infections are common forms of sexually transmitted diseases (STD). Current diagnostic procedures for these organisms are lengthy, laborious, and relatively insensitive and non-specific. A novel DNA-based diagnostic assay for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis is described in this proposal. DNA probes specific for each of these organisms are currently available. DNA hybridization procedures using non-radioactive, biotinylated DNA probes were determined in our Phase I studies. Phase II of this project will focus on the development of rapid, user friendly non-growth assays for N. gonorrhoeae and C. trachomatis using biotin-based dot blot, in situ, or Sandwich type DNA detection systems. This approach has been successfully applied to the clinical diagnosis of herpes simplex viruses. Major emphasis will be placed on determining appropriate sample format, fixation, and hybridization conditions. In concurrent studies, the use of synthetic oligonucleotides will be developed as an alternate probe technology. While currently used procedures for probe preparation from recombinant sources will be adequate for the near term, the use of synthetic oligonucleotides may offer significant advantages with respect to cost, ease, and reproducibility for large scale production.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R44
  • Administering IC
    AI
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    ENZO BIOCHEM, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    NEW YORK
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    10013
  • Organization District
    UNITED STATES